Understanding the role of COVID-19 vaccination in all-cause healthcare resource utilisation among adults with long COVID in the UK primary care setting: data from the 2022–2023 respiratory virus season
COVID-19 vaccination was not consistently associated with incidence of long COVID or all-cause HCRU. Findings suggest potential subgroup-specific benefits, highlighting the importance of annual vaccination. Further research with larger sample size and longer-term follow-up is warranted.
Authors
- Hannah R. Volkman (ORCID: https://orcid.org/0000-0001-7274-9641)
- Kiran K Rai (ORCID: https://orcid.org/0000-0002-3250-0275)
- Cale Harrison
- Rebecca Butfield (ORCID: https://orcid.org/0009-0005-8521-1863)
- Rosie Hulme
- David Gruben (ORCID: https://orcid.org/0000-0003-3516-5289)
- Jennifer L. Nguyen
- Hannah Gowman (ORCID: https://orcid.org/0009-0008-0347-4670)
- Jingyan Yang
Institutions
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Adelphi Group (United Kingdom) (GB)
- Columbia University (US)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1080/14760584.2025.2589215
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00